| Soyasaponin Bb inhibits the recruitment of toll-like receptor 4 (TLR4) into lipid rafts and its signaling pathway by suppressing the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent generation of reactive oxygen species. | Mol Nutr Food Res | 2016 Jul | 27005845 |
| Evaluation of an immunochromatographic test for feline AB system blood typing. | J Vet Emerg Crit Care (San Antonio) | 2016 Jan-Feb | 26264678 |
| Hepatoprotective effects of soluble rice protein in primary hepatocytes and in mice. | J Sci Food Agric | 2016 Jan 30 | 25715660 |
| The mycotoxin patulin reacts with DNA bases with and without previous conjugation to GSH: implication for related α,β-unsaturated carbonyl compounds? | Arch Toxicol | 2016 Feb | 25537190 |
| Dietary Supplementation with α-Ketoglutarate Activates mTOR Signaling and Enhances Energy Status in Skeletal Muscle of Lipopolysaccharide-Challenged Piglets. | J Nutr | 2016 Aug | 27385764 |
| Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial. | Lancet HIV | 2016 Apr | 27036991 |
| Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease. | Pharmacol Biochem Behav | 2015 Nov | 26394281 |
| Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid. | Toxicol Mech Methods | 2015 Mar | 25894564 |
| Protective roles of aldo-keto reductase 1B10 and autophagy against toxicity induced by p-quinone metabolites of tert-butylhydroquinone in lung cancer A549 cells. | Chem Biol Interact | 2015 Jun 5 | 25289770 |
| Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. | Lancet | 2015 Jun 27 | 25890673 |